相似文献
1
Prevention and management of non-steroidal anti-inflammatory drugs-induced small intestinal injury.
World J Gastroenterol. 2011 Nov 14;17(42):4647-53. doi: 10.3748/wjg.v17.i42.4647.
2
Non-steroidal anti-inflammatory drug induced injury to the small intestine.
Acta Medica (Hradec Kralove). 2010;53(1):3-11.
3
Present status and strategy of NSAIDs-induced small bowel injury.
J Gastroenterol. 2009;44(9):879-88. doi: 10.1007/s00535-009-0102-2. Epub 2009 Jul 1.
4
Long-term effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective agents on the small bowel: a cross-sectional capsule enteroscopy study.
Clin Gastroenterol Hepatol. 2007 Sep;5(9):1040-5. doi: 10.1016/j.cgh.2007.04.031. Epub 2007 Jul 10.
5
Capsule endoscopic diagnosis of nonsteroidal antiinflammatory drug-induced enteropathy.
J Gastroenterol. 2009;44 Suppl 19:64-71. doi: 10.1007/s00535-008-2248-8. Epub 2009 Jan 16.
6
Non-steroidal anti-inflammatory drugs-induced small intestinal injury and probiotic agents.
World J Gastroenterol. 2012 Aug 21;18(31):4241-2. doi: 10.3748/wjg.v18.i31.4241.
7
Review article: a practical approach to the clinical management of NSAID enteropathy.
Scand J Gastroenterol. 2017 Sep;52(9):941-947. doi: 10.1080/00365521.2017.1335769. Epub 2017 Jun 6.
8
Anti-tumour necrosis factor agents reduce non-steroidal anti-inflammatory drug-induced small bowel injury in rheumatoid arthritis patients.
Gut. 2014 Mar;63(3):409-14. doi: 10.1136/gutjnl-2013-304713. Epub 2013 May 22.
9
Prevention of traditional NSAID-induced small intestinal injury: recent preliminary studies using capsule endoscopy.
Digestion. 2010;82(3):167-72. doi: 10.1159/000308361. Epub 2010 Jun 25.
10
Is non-steroidal anti-inflammaory drug (NSAID) enteropathy clinically more important than NSAID gastropathy?
Postgrad Med J. 2006 Mar;82(965):186-91. doi: 10.1136/pgmj.2005.039586.
引用本文的文献
1
Resveratrol mitigates aspirin-induced intestinal injury in rats in a high-altitude hypoxic environment associated with reducing the expression levels of angiotensin II.
BMC Gastroenterol. 2025 Aug 27;25(1):623. doi: 10.1186/s12876-025-04248-5.
2
NSAIDs, Ileal Inflammation, and Glucose Metabolism: Insights from a Large Retrospective Cohort.
Nutrients. 2025 Apr 29;17(9):1514. doi: 10.3390/nu17091514.
3
Effect of tegoprazan, a novel potassium-competitive acid blocker, on non-steroidal anti-inflammatory drug (NSAID)-induced enteropathy.
Sci Rep. 2024 Nov 8;14(1):27173. doi: 10.1038/s41598-024-78581-2.
4
Troxerutin effect on gastric ulcers induced by ketorolac in rats: Relation with oxidative stress.
Heliyon. 2024 Oct 3;10(19):e38893. doi: 10.1016/j.heliyon.2024.e38893. eCollection 2024 Oct 15.
5
Massive Gastrointestinal Bleeding Related to NSAID Use in a Patient with Ileorectal Anastomosis.
Case Rep Surg. 2024 Aug 30;2024:4619458. doi: 10.1155/2024/4619458. eCollection 2024.
6
Exposure to Radiofrequency Induces Synaptic Dysfunction in Cortical Neurons Causing Learning and Memory Alteration in Early Postnatal Mice.
Int J Mol Sci. 2024 Aug 6;25(16):8589. doi: 10.3390/ijms25168589.
7
DA-9601 has protective effects comparable to those of proton pump inhibitor and rebamipide against nonsteroidal anti-inflammatory drugs-induced upper and lower gastrointestinal bleeding in patients with rheumatoid arthritis: A nationwide study using Korean Health Insurance Review and Assessment Service database.
Medicine (Baltimore). 2024 Jul 5;103(27):e38801. doi: 10.1097/MD.0000000000038801.
8
A novel drug-like water-soluble small molecule Focal Adhesion Kinase (FAK) activator promotes intestinal mucosal healing.
Curr Res Pharmacol Drug Discov. 2022 Dec 23;4:100147. doi: 10.1016/j.crphar.2022.100147. eCollection 2023.
9
The effect of rebamipide on non-steroidal anti-inflammatory drug-induced gastro-enteropathy: a multi-center, randomized pilot study.
Korean J Intern Med. 2022 Nov;37(6):1153-1166. doi: 10.3904/kjim.2021.216. Epub 2022 Nov 1.
10
Small Intestinal Perforation Caused by Enteric-coated Low-dose Aspirin.
Intern Med. 2023 Jan 15;62(2):233-235. doi: 10.2169/internalmedicine.9681-22. Epub 2022 Jun 21.
本文引用的文献
1
NSAID acyl glucuronides and enteropathy.
Curr Drug Metab. 2011 Mar;12(3):245-52. doi: 10.2174/138920011795101877.
2
Prevention by lansoprazole, a proton pump inhibitor, of indomethacin -induced small intestinal ulceration in rats through induction of heme oxygenase-1.
J Physiol Pharmacol. 2010 Jun;61(3):287-94.
3
Prevention of traditional NSAID-induced small intestinal injury: recent preliminary studies using capsule endoscopy.
Digestion. 2010;82(3):167-72. doi: 10.1159/000308361. Epub 2010 Jun 25.
4
Rescue strategies against non-steroidal anti-inflammatory drug-induced gastroduodenal damage.
J Gastroenterol Hepatol. 2009 Jul;24(7):1169-78. doi: 10.1111/j.1440-1746.2009.05929.x.
5
Incidence of small bowel injury induced by low-dose aspirin: a crossover study using capsule endoscopy in healthy volunteers.
Digestion. 2009;79(1):44-51. doi: 10.1159/000204465. Epub 2009 Feb 26.
6
Prevention of nonsteroidal anti-inflammatory drug-induced small-intestinal injury by prostaglandin: a pilot randomized controlled trial evaluated by capsule endoscopy.
Gastrointest Endosc. 2009 Jun;69(7):1339-46. doi: 10.1016/j.gie.2008.08.017. Epub 2009 Feb 24.
7
Guidelines for prevention of NSAID-related ulcer complications.
Am J Gastroenterol. 2009 Mar;104(3):728-38. doi: 10.1038/ajg.2009.115. Epub 2009 Feb 24.
8
Capsule endoscopic diagnosis of nonsteroidal antiinflammatory drug-induced enteropathy.
J Gastroenterol. 2009;44 Suppl 19:64-71. doi: 10.1007/s00535-008-2248-8. Epub 2009 Jan 16.
9
Nonsteroidal anti-inflammatory drug-induced small-bowel lesions identified by double-balloon endoscopy: endoscopic features of the lesions and endoscopic treatments for diaphragm disease.
J Gastroenterol. 2009;44 Suppl 19:57-63. doi: 10.1007/s00535-008-2277-3. Epub 2009 Jan 16.
10
Intestinal permeability in the pathogenesis of NSAID-induced enteropathy.
J Gastroenterol. 2009;44 Suppl 19:23-9. doi: 10.1007/s00535-008-2266-6. Epub 2009 Jan 16.
Zotero 插件